These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2881101)

  • 1. N-myc oncogene amplification and catecholamine metabolism in children with neuroblastoma.
    Nakagawara A; Ikeda K
    Lancet; 1987 Mar; 1(8532):559. PubMed ID: 2881101
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.
    Kerbl R; Urban C; Starz I; Ambros IM; Strehl S; Kovar H; Gadner H; Ambros PF
    Med Pediatr Oncol; 1993; 21(9):625-6. PubMed ID: 8412992
    [No Abstract]   [Full Text] [Related]  

  • 3. Catecholamine measurements in pheochromocytoma and neuroblastoma.
    Spiegel HE
    Ann Clin Lab Sci; 1974; 4(3):174-7. PubMed ID: 4363482
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
    Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH; Oberrauch W; Schanz F; Treuner J
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamine metabolism in the carcinoid syndrome.
    Feldman JM; Butler SS; Chapman BA; Bivens CE
    Clin Chim Acta; 1974 Feb; 51(1):75-81. PubMed ID: 4822816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group.
    Pritchard J; Barnes J; Germond S; Hartman O; de Kraker J; Lewis I; Lockwood L; Wallendszus K
    Lancet; 1989 Aug; 2(8661):514-5. PubMed ID: 2570230
    [No Abstract]   [Full Text] [Related]  

  • 11. Normal urinary excretion of catecholamine catabolites in children with retinoblastoma.
    Orlowski JP; Levin HS; Price RL; Dyment PG
    Med Pediatr Oncol; 1978; 4(4):343-9. PubMed ID: 723798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G; Falcone R; De Bernardi B; Canini S
    Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and histologic determinants in the prognosis of neuroblastoma.
    Gitlow SE; Dziedzic LB; Strauss L; Greenwood SM; Dziedzic SW
    Cancer; 1973 Oct; 32(4):898-905. PubMed ID: 4751920
    [No Abstract]   [Full Text] [Related]  

  • 15. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: implications for ophthalmic practice.
    Smith SJ; Diehl NN; Smith BD; Mohney BG
    Eye (Lond); 2010 Dec; 24(12):1792-6. PubMed ID: 20865029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification.
    Parodi S; Papio F; Haupt R; Conte M; De Bernardi B
    Pediatr Blood Cancer; 2007 May; 48(5):593; author reply 593-4. PubMed ID: 16937359
    [No Abstract]   [Full Text] [Related]  

  • 17. DNA ploidy in neuroblastoma.
    Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
    Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory techniques and neuroblastoma screening.
    Sawada T
    Lancet; 1988 Nov; 2(8620):1134-5. PubMed ID: 2903341
    [No Abstract]   [Full Text] [Related]  

  • 19. Olive ingestion causing a false suspicion of relapsed neuroblastoma: A case of "oliveblastoma?".
    Flynn N; LeFebvre A; Messahel B; Hogg SL
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27248. PubMed ID: 29923309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Catecholamine excretion levels in neuroblastoma.
    Wilson LM
    Br Med J; 1974 Oct; 4(5936):105. PubMed ID: 4414139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.